Findings

What do systematic reviews say?

6 questions · 6 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 3 · 50%GRADE not reported 0 · 0%Very low 2 · 33.3%Low 1 · 16.7%Moderate 0 · 0%High 0 · 0%

Summary of findings for subcutaneous terbutaline with continuation of oxytocic infusion vs cessation of oxytocic infusion without tocolytic agent

Perinatal death or severe morbidity · women who developed uterine hyperstimulation in labour with oxytocin augmentation, but without signs of fetal distress

The review found no eligible studies for this question.

1 finding from 1 review

Acute tocolysis for uterine tachysystole or suspected fetal distress 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings for subcutaneous terbutaline with continuation of oxytocic infusion vs cessation of oxytocic infusion without tocolytic agent

Fetal or neonatal mortality · women who developed uterine hyperstimulation in labour with oxytocin augmentation, but without signs of fetal distress

The review found no eligible studies for this question.

1 finding from 1 review

Acute tocolysis for uterine tachysystole or suspected fetal distress 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings for subcutaneous terbutaline with continuation of oxytocic infusion vs cessation of oxytocic infusion without tocolytic agent

Caesarean section · women who developed uterine hyperstimulation in labour with oxytocin augmentation, but without signs of fetal distress

Summary of findings for subcutaneous terbutaline with continuation… showed no clear difference in caesarean delivery compared with cessation of oxytocic infusion without tocolytic agent (low certainty).

1 finding from 1 review

Acute tocolysis for uterine tachysystole or suspected fetal distress 2018 · Cochrane Headline outcomes only
RR 1.73 [0.68, 4.45]
1 study · 28 participants
Low

Summary of findings for subcutaneous terbutaline with continuation of oxytocic infusion vs cessation of oxytocic infusion without tocolytic agent

Apgar score less than 7 at 5 minutes · women who developed uterine hyperstimulation in labour with oxytocin augmentation, but without signs of fetal distress

1 finding from 1 review

Acute tocolysis for uterine tachysystole or suspected fetal distress 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 28 participants
Very low

Summary of findings for subcutaneous terbutaline with continuation of oxytocic infusion vs cessation of oxytocic infusion without tocolytic agent

Umbilical artery pH < 7.0 · women who developed uterine hyperstimulation in labour with oxytocin augmentation, but without signs of fetal distress

1 finding from 1 review

Acute tocolysis for uterine tachysystole or suspected fetal distress 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 28 participants
Very low

Summary of findings for subcutaneous terbutaline with continuation of oxytocic infusion vs cessation of oxytocic infusion without tocolytic agent

Abnormal FHR tracing · women who developed uterine hyperstimulation in labour with oxytocin augmentation, but without signs of fetal distress

The review found no eligible studies for this question.

1 finding from 1 review

Acute tocolysis for uterine tachysystole or suspected fetal distress 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found